Abu Dhabi, United Arab Emirates: Abu Dhabi Health Services Company (SEHA), the UAE’s largest healthcare network, participated in the World Sepsis Congress Spotlight 2020. The event, co-organized by the World Health Organization (WHO) and the Global Sepsis Alliance (GSA), was held virtually in Berlin, Germany. This year’s theme focused on ‘Sepsis, Pandemics, and Antimicrobial Resistance – Global Health Threats of the 21st Century’, shedding light on challenges and lessons learnt from the COVID-19 pandemic. The event united the world’s most prominent healthcare professionals who shared their insights during six different sessions.
The event coincided with World Sepsis Day, which is a global initiative by GSA to emphasize the threat of Sepsis as a public health risk, explain its impact on patient mortality rates, and advocacy of strong measures to combat the condition globally. Sepsis results from the dysregulated immune system response to infections, which leads to organ failure and death. Each year sepsis affects close to 50 million people of which more than 40% are children under the age of 5 years old.
As part of the fourth session titled ‘Sepsis, Ebola, and COVID-19’, Dr. Hala Abu Zeid, Chair of the Critical Care Department, Tawam Hospital, a SEHA healthcare facility, discussed special considerations for managing sepsis in COVID-19 patients. The session was chaired by Dr. Emmanuel Nsutebu, Chief of Infectious Diseases at Sheikh Shakhbout Medical City, a SEHA facility in partnership with Mayo Clinic, and Chair of African Sepsis Alliance.
Dr. Abu Zeid commented on SEHA’s participation in the event, saying, “Sepsis is a dangerous threat to our communities, and its threat has now increased as we are in the midst of an ongoing battle against a global pandemic. COVID-19 takes a toll on the human body, sometimes affecting the entire body and its functions. According to studies by the WHO, there is concrete evidence linking COVID-19 as a cause for Sepsis and therefore adding an additional burden to our healthcare providers.”
Dr. Nsutebu shared his insights on SEHA’s response to Sepsis during the pandemic, commenting, “At SEHA, we remain committed to the delivery of world class health care services. Through the excellent COVID-19 response of the UAE government, and their support of our healthcare facilities, the number of deaths and critical patients has remained relatively low and this is a testament to a much brighter future ahead. I would like to thank WHO and GSA who have brought a very important health issue to light, and their joint efforts in protecting all communities worldwide.”
To watch the recording of the session, please visit any of the following links:
Apple Podcasts on the App Store:https://podcasts.apple.com/us/podcast/2020-wsc-spotlight-sepsis-pandemics-antimicrobial-resistance/id1155062518?app=podcast&mt=2
The Abu Dhabi Health Services Company PJSC–SEHA – is an independent, public joint stock company created to develop the curative activities of the public healthcare system in Abu Dhabi. The company owns and operates all the public hospitals and clinics of the Emirate of Abu Dhabi.
SEHA is part of ADQ, one of the region’s largest holding companies with a broad portfolio of major enterprises spanning key sectors of Abu Dhabi’s diversified economy.
SEHA is committed to continuous improvement of customer care to recognized international standards and providing the community with world-class healthcare. SEHA operates 13 hospitals with 3,385 beds, 70 ambulatory care, family care and urgent care centers and 2 blood banks. Its facilities accommodate 11,7162 inpatients annually and conduct 43,262 surgeries, as well as treating more than five million outpatients. SEHA is one of the largest integrated healthcare providers in the Middle East with more than 18,000 doctors, nurses, ancillary care, and administrative personnel. Learn more at www.seha.ae
© Press Release 2020